Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

87.11
-0.3600-0.41%
Post-market: 87.02-0.0900-0.10%19:30 EDT
Volume:1.09M
Turnover:94.72M
Market Cap:12.27B
PE:-38.14
High:88.46
Open:87.90
Low:85.94
Close:87.47
52wk High:95.49
52wk Low:20.45
Shares:140.86M
Float Shares:122.00M
Volume Ratio:1.09
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:26.36
PE(LYR):-7,144.26

Loading ...

Arrowhead Pharmaceuticals : JP Morgan Raises Target Price to $95 from $88

THOMSON REUTERS
·
Jul 17

U.S. Research Roundup-ibm, MSCI, US Bancorp

Reuters
·
Jul 17

Stifel Initiates Arrowhead Pharmaceuticals at Buy With $98 Price Target

MT Newswires Live
·
Jul 14

Arrowhead Pharmaceuticals : Stifel Initiates Coverage with Buy Rating; Target Price $98

THOMSON REUTERS
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and BrightSpring Health Services, Inc. (BTSG)

TIPRANKS
·
Jul 14

Arrowhead initiated with a Buy at Stifel

TIPRANKS
·
Jul 14

Can Biogen Convince Skeptics That Cutting a Rogue Protein Slows Alzheimer's?

Dow Jones
·
Jul 13

Arrowhead Pharmaceuticals Inc Stock (ARWR) Moved Down by 7.27% on Jul 10: What Signal Does It Send?

TradingKey
·
Jul 11

Movement Alert|Arrowhead Research Corporation Falls 7.92% in Regular Trading, Trading at $77.45

Market Focus
·
Jul 11

Arrowhead Pharmaceuticals (ARWR) Is Up 6.6% After Russell Index Upgrade Has The Bull Case Changed?

Simply Wall St.
·
Jul 09

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jul 06

Arrowhead Pharmaceuticals (ARWR) Joins Larger Indexes After EU Approval, Is It Still Cheap?

Simply Wall St.
·
Jul 06

Is EU REDEMPLO Approval For Clinically Diagnosed FCS Patients Altering The Investment Case For Arrowhead Pharmaceuticals (ARWR)?

Simply Wall St.
·
Jul 02

Arrowhead Pharmaceuticals Price Target Maintained with a $100.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 02

Arrowhead Pharmaceuticals is Maintained at Buy by Chardan Capital

Dow Jones
·
Jun 30

Arrowhead Pharmaceuticals (ARWR) Receives a Buy from Piper Sandler

TIPRANKS
·
Jun 30

Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (ARWR) and CSL (OtherCMXHF)

TIPRANKS
·
Jun 30

Arrowhead Pharmaceuticals Posts Cardiometabolic R&D Webinar Presentation

Reuters
·
Jun 30

Analysts’ Top Healthcare Picks: Eton Pharmaceuticals (ETON), Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jun 27

Arrowhead receives MAA in the EU for REDEMPLO

TIPRANKS
·
Jun 23